LipoScience, Inc. is a clinical diagnostic company. The Company’s diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company’s Vantera system represents the research in the field of personalized diagnostics. The Company's NMR LipoProfile test directly quantifies low density lipoprotein particles (LDL-P) circulating in the body. As of December 31, 2013, over 11 million NMR LipoProfile tests were ordered.